test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
RIGLRigel Pharmaceuticals Inc
Recent Activity
Decreased -10.43%
1.18%
$15.125M
934,788 shares@ $16.19 avg price
PRAXPraxis Precision Medicines I
Recent Activity
Decreased -51.33%
1.16%
$14.926M
259,398 shares@ $57.55 avg price
CGONCg Oncology Inc
Recent Activity
Decreased -19.78%
1%
$12.85M
340,585 shares@ $37.73 avg price
ENTAEnanta Pharmaceuticals Inc
Recent Activity
Decreased -1.75%
0.64%
$8.138M
785,546 shares@ $10.37 avg price
KIDSOrthopediatrics Corp
Recent Activity
Decreased -6.64%
0.61%
$7.833M
288,945 shares@ $27.12 avg price
ACLXArcellx Inc
Recent Activity
Decreased -45.51%
0.61%
$7.769M
93,031 shares@ $83.52 avg price
NUVLNuvalent Inc
Recent Activity
Decreased -56.71%
0.59%
$7.607M
74,357 shares@ $102.3 avg price
BDSXBiodesix Inc
Recent Activity
Decreased -33.93%
0.56%
$7.188M
4.038M shares@ $1.79 avg price
ELVNEnliven Therapeutics Inc
Recent Activity
Decreased -68.83%
0.48%
$6.122M
239,705 shares@ $25.55 avg price
APLTApplied Therapeutics Inc
Recent Activity
Decreased -46.38%
0.45%
$5.787M
680,784 shares@ $8.5 avg price